Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT02196220
Eligibility Criteria:
Inclusion Criteria:
For the first arm of the study (25 participants):
* Children with mucopolysaccharidosis presenting to the senior author's clinic with signs or symptoms of carpal tunnel syndrome will be enrolled to receive both an EMG and carpal tunnel ultrasound of the upper extremities.
For the second arm of the study (100 participants):
* Healthy children ages 3-12 with no acute upper extremity trauma or history of mucopolysaccharidosis.
* 25 additional participants requested in case of inconclusive ultrasound results, patient removal, or other unusable results.
Exclusion Criteria:
First arm:
* Children with mucopolysaccharidosis who have undergone previous treatment for carpal tunnel syndrome.
Second arm:
* Acute (\<3month) wrist or hand surgery/injuries.
* Unable to obtain parental consent or patient assent.
* History of mucopolysaccharidosis.
* Non-english speaking.
* Cognitive impairment.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
12 Years
Study:
NCT02196220
Study Brief:
Protocol Section:
NCT02196220